Ted Hisokawa
Jan 14, 2025 08:13
NVIDIA partners with industry giants to advance genomics, drug discovery, and healthcare using AI and accelerated computing, aiming to transform the $10 trillion healthcare industry.
NVIDIA has announced strategic partnerships with leading organizations in the healthcare and life sciences sectors, aiming to revolutionize genomics, drug discovery, and healthcare services. The collaboration involves industry giants such as IQVIA, Illumina, Mayo Clinic, and the Arc Institute, leveraging NVIDIA’s advanced AI and accelerated computing technologies, according to NVIDIA Newsroom.
Transforming Healthcare with AI
The convergence of AI, accelerated computing, and biological data is positioning healthcare as a leading technology industry. The collaboration aims to harness NVIDIA’s capabilities to develop solutions that can significantly enhance human health. These solutions include AI agents to expedite clinical trials, AI models for drug discovery and digital pathology, and AI robots for surgical and operational support.
Kimberly Powell, Vice President of Healthcare at NVIDIA, stated, “AI offers an exceptional opportunity to advance healthcare and life sciences with tools that help providers detect diseases earlier and discover new treatments faster.” This initiative is expected to create an AI factory opportunity worth hundreds of billions of dollars.
IQVIA’s AI-Driven Innovations
IQVIA, a leader in clinical research services and healthcare intelligence, is utilizing NVIDIA’s AI Foundry service to build custom foundation models. These models will be developed using over 64 petabytes of data, aiming to accelerate research and clinical development. The company is committed to ensuring its AI-powered capabilities adhere to privacy, regulatory compliance, and patient safety standards.
Illumina’s Genomic Advancements
Illumina, renowned for its DNA sequencing technologies, is collaborating with NVIDIA to enhance genomics for drug discovery. This partnership will enable Illumina to integrate NVIDIA’s AI tools into its multiomics analysis software, expanding access to genomic insights for researchers and pharmaceutical companies worldwide. The collaboration also aims to advance multiomics data analysis and develop new biology foundation models.
Mayo Clinic’s Pathology Innovations
Mayo Clinic is set to accelerate the development of pathology foundation models using NVIDIA’s technology. Their Digital Pathology platform, which includes a vast dataset of whole-slide images and patient records, will benefit from NVIDIA’s DGX Blackwell systems and healthcare imaging platform MONAI. This partnership focuses on enhancing personalized diagnostics and treatment strategies.
Arc Institute’s AI Model Development
In collaboration with NVIDIA, Arc Institute is developing AI models to advance biomedical discovery. By combining expertise in biology and machine learning, the partnership aims to create scalable foundation models that can generalize across various biological modalities. NVIDIA’s support includes providing its BioNeMo platform and expertise in large-scale model development.
Through these partnerships, NVIDIA and its collaborators are poised to make significant strides in the healthcare and life sciences industries, potentially transforming how diseases are understood and treated globally.
Image source: Shutterstock
Credit: Source link
